{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:37:40Z","timestamp":1794652660886,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The benzodiazepine midazolam is a \u03b3-aminobutyric acid (GABA)-A receptor agonist frequently used for sedation or stress control in patients suffering from traumatic brain injury (TBI). However, experimental studies on benzodiazepines have reported divergent results, raising concerns about its widespread use in patients. Some studies indicate that benzodiazepine-mediated potentiation of GABAergic neurotransmission is detrimental in brain-injured animals. However, other experimental investigations demonstrate neuroprotective effects, especially in pretreatment paradigms. This study investigated whether single-bolus midazolam administration influences secondary brain damage post-TBI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Two different midazolam dosages (0.5 and 5 mg\/kg BW), a combination of midazolam and its competitive antagonist flumazenil, or vehicle solution (NaCl 0.9%) was injected intravenously to mice 24 h after experimental TBI induced by controlled cortical impact. Mice were evaluated for neurological and motor deficits using a 15-point neuroscore and the rotarod test. Histopathological brain damage and mRNA expression of inflammatory marker genes were analyzed using quantitative polymerase chain reaction three days after insult.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Histological brain damage was not affected by posttraumatic midazolam administration. Midazolam impaired functional recovery, and this effect could not be counteracted by administering the midazolam antagonist flumazenil. An increase in\n                      <jats:italic>IL-1\u03b2<\/jats:italic>\n                      mRNA levels due to postinjury application of midazolam was reversible by flumazenil administration. However, other inflammatory parameters were not affected.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study merely reports minor effects of a postinjury midazolam application. Further studies focusing on a time-dependent analysis of posttraumatic benzodiazepine administration are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-022-01592-x","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T08:38:34Z","timestamp":1646383114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Posttraumatic midazolam administration does not influence brain damage after experimental traumatic brain injury"],"prefix":"10.1186","volume":"22","author":[{"given":"Anne","family":"Sebastiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K. E.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge C.","family":"Thal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"issue":"12","key":"1592_CR1","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1097\/CCM.0b013e318228236f","volume":"39","author":"DJ Roberts","year":"2011","unstructured":"Roberts DJ, Hall RI, Kramer AH, Robertson HL, Gallagher CN, Zygun DA. Sedation for critically ill adults with severe traumatic brain injury: a systematic review of randomized controlled trials. Crit Care Med. 2011;39(12):2743\u201351.","journal-title":"Crit Care Med"},{"issue":"2","key":"1592_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2165\/00002018-200427020-00003","volume":"27","author":"SC Urwin","year":"2004","unstructured":"Urwin SC, Menon DK. Comparative tolerability of sedative agents in head-injured adults. Drug Safety. 2004;27(2):107\u201333.","journal-title":"Drug Safety"},{"issue":"4","key":"1592_CR3","first-page":"e2530","volume":"10","author":"N Kramer","year":"2018","unstructured":"Kramer N, Lebowitz D, Walsh M, Ganti L. Rapid Sequence Intubation in Traumatic Brain-injured Adults. Cureus. 2018;10(4):e2530.","journal-title":"Cureus"},{"issue":"1","key":"1592_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13054-016-1294-5","volume":"20","author":"M Oddo","year":"2016","unstructured":"Oddo M, Crippa IA, Mehta S, Menon D, Payen JF, Taccone FS, et al. Optimizing sedation in patients with acute brain injury. Critical Care. 2016;20(1):128.","journal-title":"Critical Care"},{"key":"1592_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.wneu.2017.07.009","volume":"106","author":"AM Alnemari","year":"2017","unstructured":"Alnemari AM, Krafcik BM, Mansour TR, Gaudin D. A comparison of pharmacologic therapeutic agents used for the reduction of intracranial pressure after traumatic brain injury. World Neurosurg. 2017;106:509\u201328.","journal-title":"World Neurosurg"},{"issue":"2","key":"1592_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/bja\/71.2.267","volume":"71","author":"L Papazian","year":"1993","unstructured":"Papazian L, Albanese J, Thirion X, Perrin G, Durbec O, Martin C. Effect of bolus doses of midazolam on intracranial pressure and cerebral perfusion pressure in patients with severe head injury. Bri J Anaesth. 1993;71(2):267\u201371.","journal-title":"Bri J Anaesth"},{"issue":"1","key":"1592_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-4328(05)80306-7","volume":"51","author":"TA Jones","year":"1992","unstructured":"Jones TA, Schallert T. Subcortical deterioration after cortical damage: effects of diazepam and relation to recovery of function. Behav Brain Res. 1992;51(1):1\u201313.","journal-title":"Behav Brain Res"},{"issue":"2","key":"1592_CR8","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1097\/CCM.0000000000001284","volume":"44","author":"A Sebastiani","year":"2016","unstructured":"Sebastiani A, Granold M, Ditter A, Sebastiani P, Golz C, Pottker B, et al. Posttraumatic Propofol Neurotoxicity Is Mediated via the Pro-Brain-Derived Neurotrophic Factor-p75 Neurotrophin Receptor Pathway in Adult Mice. Crit Care Med. 2016;44(2):e70\u201382.","journal-title":"Crit Care Med"},{"issue":"1","key":"1592_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/CCM.0b013e3182a639fd","volume":"42","author":"SC Thal","year":"2014","unstructured":"Thal SC, Timaru-Kast R, Wilde F, Merk P, Johnson F, Frauenknecht K, et al. Propofol impairs neurogenesis and neurologic recovery and increases mortality rate in adult rats after traumatic brain injury. Crit Care Med. 2014;42(1):129\u201341.","journal-title":"Crit Care Med"},{"issue":"3","key":"1592_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1089\/neu.2009.1142","volume":"27","author":"PG Ochalski","year":"2010","unstructured":"Ochalski PG, Fellows-Mayle W, Hsieh LB, Srinivas R, Okonkwo DO, Dixon CE, et al. Flumazenil administration attenuates cognitive impairment in immature rats after controlled cortical impact. J Neurotrauma. 2010;27(3):647\u201351.","journal-title":"J Neurotrauma"},{"issue":"2","key":"1592_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0006-8993(00)02055-2","volume":"861","author":"DM O'Dell","year":"2000","unstructured":"O'Dell DM, Gibson CJ, Wilson MS, DeFord SM, Hamm RJ. Positive and negative modulation of the GABA(A) receptor and outcome after traumatic brain injury in rats. Brain Res. 2000;861(2):325\u201332.","journal-title":"Brain Res"},{"key":"1592_CR12","doi-asserted-by":"publisher","first-page":"637171","DOI":"10.1155\/2012\/637171","volume":"2012","author":"O Flower","year":"2012","unstructured":"Flower O, Hellings S. Sedation in traumatic brain injury. Emerg Med Int. 2012;2012:637171.","journal-title":"Emerg Med Int"},{"issue":"20","key":"1592_CR13","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1089\/neu.2014.3751","volume":"32","author":"A Sebastiani","year":"2015","unstructured":"Sebastiani A, Golz C, Werner C, Schafer MK, Engelhard K, Thal SC. Proneurotrophin Binding to P75 Neurotrophin Receptor (P75ntr) Is Essential for Brain Lesion Formation and Functional Impairment after Experimental Traumatic Brain Injury. J Neurotrauma. 2015;32(20):1599\u2013607.","journal-title":"J Neurotrauma"},{"key":"1592_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jneumeth.2016.11.012","volume":"276","author":"A Sebastiani","year":"2017","unstructured":"Sebastiani A, Hirnet T, Jahn-Eimermacher A, Thal SC. Comparison of speed-vacuum method and heat-drying method to measure brain water content of small brain samples. J Neurosci Methods. 2017;276:73\u20138.","journal-title":"J Neurosci Methods"},{"issue":"2","key":"1592_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1096\/fj.02-0611fje","volume":"17","author":"R Jurd","year":"2003","unstructured":"Jurd R, Arras M, Lambert S, Drexler B, Siegwart R, Crestani F, et al. General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit. FASEB J. 2003;17(2):250\u20132.","journal-title":"FASEB J"},{"issue":"5","key":"1592_CR16","first-page":"443","volume":"51","author":"M Arras","year":"2001","unstructured":"Arras M, Autenried P, Rettich A, Spaeni D, Rulicke T. Optimization of intraperitoneal injection anesthesia in mice: drugs, dosages, adverse effects, and anesthesia depth. Comparative Med. 2001;51(5):443\u201356.","journal-title":"Comparative Med"},{"key":"1592_CR17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3389\/fnins.2017.00678","volume":"11","author":"A Sebastiani","year":"2017","unstructured":"Sebastiani A, Golz C, Sebastiani PG, Bobkiewicz W, Behl C, Mittmann T, et al. Sequestosome 1 Deficiency Delays, but Does Not Prevent Brain Damage Formation Following Acute Brain Injury in Adult Mice. Front Neurosci. 2017;11:678.","journal-title":"Front Neurosci"},{"issue":"4","key":"1592_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1089\/neu.2007.0452","volume":"25","author":"J Tsenter","year":"2008","unstructured":"Tsenter J, Beni-Adani L, Assaf Y, Alexandrovich AG, Trembovler V, Shohami E. Dynamic changes in the recovery after traumatic brain injury in mice: effect of injury severity on T2-weighted MRI abnormalities, and motor and cognitive functions. J Neurotrauma. 2008;25(4):324\u201333.","journal-title":"J Neurotrauma"},{"key":"1592_CR19","first-page":"S200","volume":"29","author":"R Timaru-Kast","year":"2009","unstructured":"Timaru-Kast R, Ricken C, Engelhard K, Werner C, Thal S. Low dose AT1 inhibition improves neurological outcome and reduces secondary brain damage 24 h after brain trauma in mice. J Cerebral Blood Flow Metab. 2009;29:S200.","journal-title":"J Cerebral Blood Flow Metab"},{"issue":"5","key":"1592_CR20","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1097\/CCM.0b013e31827ca494","volume":"41","author":"SC Thal","year":"2013","unstructured":"Thal SC, Schaible EV, Neuhaus W, Scheffer D, Brandstetter M, Engelhard K, et al. Inhibition of proteasomal glucocorticoid receptor degradation restores dexamethasone-mediated stabilization of the blood-brain barrier after traumatic brain injury. Crit Care Med. 2013;41(5):1305\u201315.","journal-title":"Crit Care Med"},{"issue":"7","key":"1592_CR21","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1089\/neu.2007.0497","volume":"25","author":"SC Thal","year":"2008","unstructured":"Thal SC, Wyschkon S, Pieter D, Engelhard K, Werner C. Selection of endogenous control genes for normalization of gene expression analysis after experimental brain trauma in mice. J Neurotrauma. 2008;25(7):785\u201394.","journal-title":"J Neurotrauma"},{"issue":"2","key":"1592_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/bja\/87.2.186","volume":"87","author":"HM Soliman","year":"2001","unstructured":"Soliman HM, Melot C, Vincent JL. Sedative and analgesic practice in the intensive care unit: the results of a European survey. Bri J Anaesth. 2001;87(2):186\u201392.","journal-title":"Bri J Anaesth"},{"issue":"4","key":"1592_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1345\/aph.1Q525","volume":"46","author":"S Devabhakthuni","year":"2012","unstructured":"Devabhakthuni S, Armahizer MJ, Dasta JF, Kane-Gill SL. Analgosedation: a paradigm shift in intensive care unit sedation practice. Ann Pharmacother. 2012;46(4):530\u201340.","journal-title":"Ann Pharmacother"},{"issue":"10","key":"1592_CR24","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/01.phm.0000179438.22235.08","volume":"84","author":"LA Lombard","year":"2005","unstructured":"Lombard LA, Zafonte RD. Agitation after traumatic brain injury: considerations and treatment options. Am J Phys Med Rehabil. 2005;84(10):797\u2013812.","journal-title":"Am J Phys Med Rehabil"},{"issue":"3","key":"1592_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1155\/NP.1993.175","volume":"4","author":"LB Goldstein","year":"1993","unstructured":"Goldstein LB. Basic and clinical studies of pharmacologic effects on recovery from brain injury. J Neural Transplant Plast. 1993;4(3):175\u201392.","journal-title":"J Neural Transplant Plast"},{"issue":"6","key":"1592_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/jnnp.58.6.753","volume":"58","author":"LB Goldstein","year":"1995","unstructured":"Goldstein LB. Prescribing of potentially harmful drugs to patients admitted to hospital after head injury. J Neurol Neurosurg Psychiatry. 1995;58(6):753\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1592_CR27","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1161\/01.STR.0000056540.04159.F3","volume":"34","author":"RM Lazar","year":"2003","unstructured":"Lazar RM, Fitzsimmons BF, Marshall RS, Mohr JP, Berman MF. Midazolam challenge reinduces neurological deficits after transient ischemic attack. Stroke. 2003;34(3):794\u20136.","journal-title":"Stroke"},{"issue":"2","key":"1592_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bjp.0706301","volume":"146","author":"C Young","year":"2005","unstructured":"Young C, Jevtovic-Todorovic V, Qin YQ, Tenkova T, Wang H, Labruyere J, et al. Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Bri J Pharmacol. 2005;146(2):189\u201397.","journal-title":"Bri J Pharmacol"},{"issue":"2","key":"1592_CR29","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/ALN.0b013e318242a48c","volume":"116","author":"ML Pearn","year":"2012","unstructured":"Pearn ML, Hu Y, Niesman IR, Patel HH, Drummond JC, Roth DM, et al. Propofol neurotoxicity is mediated by p75 neurotrophin receptor activation. Anesthesiology. 2012;116(2):352\u201361.","journal-title":"Anesthesiology"},{"issue":"Suppl 1","key":"1592_CR30","doi-asserted-by":"publisher","first-page":"i29","DOI":"10.1093\/bja\/aet173","volume":"110","author":"C Creeley","year":"2013","unstructured":"Creeley C, Dikranian K, Dissen G, Martin L, Olney J, Brambrink A. Propofol-induced apoptosis of neurones and oligodendrocytes in fetal and neonatal rhesus macaque brain. Bri J Anaesth. 2013;110(Suppl 1):i29\u201338.","journal-title":"Bri J Anaesth"},{"issue":"5455","key":"1592_CR31","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.287.5455.1056","volume":"287","author":"C Ikonomidou","year":"2000","unstructured":"Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science. 2000;287(5455):1056\u201360.","journal-title":"Science"},{"issue":"5","key":"1592_CR32","doi-asserted-by":"publisher","first-page":"e19948","DOI":"10.1371\/journal.pone.0019948","volume":"6","author":"C Luh","year":"2011","unstructured":"Luh C, Gierth K, Timaru-Kast R, Engelhard K, Werner C, Thal SC. Influence of a brief episode of anesthesia during the induction of experimental brain trauma on secondary brain damage and inflammation. PLoS One. 2011;6(5):e19948.","journal-title":"PLoS One"},{"key":"1592_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neuroscience.2012.12.007","volume":"239","author":"A Shulga","year":"2013","unstructured":"Shulga A, Rivera C. Interplay between thyroxin, BDNF and GABA in injured neurons. Neuroscience. 2013;239:241\u201352.","journal-title":"Neuroscience"},{"key":"1592_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2013.03.009","volume":"1510","author":"D Hertle","year":"2013","unstructured":"Hertle D, Werhahn L, Beynon C, Zweckberger K, Vienenkotter B, Jung CS, et al. Depression of neuronal activity by sedatives is associated with adverse effects after brain injury. Brain Res. 2013;1510:1\u20139.","journal-title":"Brain Res"},{"key":"1592_CR35","first-page":"CD009622","volume":"10","author":"J Liu","year":"2016","unstructured":"Liu J, Wang LN, Ma X, Ji X. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. Cochrane Database Syst Rev. 2016;10:CD009622.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1-2","key":"1592_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0006-8993(03)02511-3","volume":"972","author":"JW Marshall","year":"2003","unstructured":"Marshall JW, Green AR, Ridley RM. Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures. Brain Res. 2003;972(1-2):119\u201326.","journal-title":"Brain Res"},{"issue":"9","key":"1592_CR37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrneurol.2017.116","volume":"13","author":"DW Simon","year":"2017","unstructured":"Simon DW, McGeachy MJ, Bayir H, Clark RSB, Loane DJ, Kochanek PM. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol. 2017;13(9):572.","journal-title":"Nat Rev Neurol"},{"key":"1592_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuro.2014.03.004","volume":"43","author":"B Viviani","year":"2014","unstructured":"Viviani B, Boraso M, Marchetti N, Marinovich M. Perspectives on neuroinflammation and excitotoxicity: a neurotoxic conspiracy? Neurotoxicology. 2014;43:10\u201320.","journal-title":"Neurotoxicology"},{"issue":"6","key":"1592_CR39","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1089\/neu.2011.1817","volume":"29","author":"M Tanguy","year":"2012","unstructured":"Tanguy M, Seguin P, Laviolle B, Bleichner JP, Morandi X, Malledant Y. Cerebral microdialysis effects of propofol versus midazolam in severe traumatic brain injury. J Neurotrauma. 2012;29(6):1105\u201310.","journal-title":"J Neurotrauma"},{"issue":"2","key":"1592_CR40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jcrc.2013.10.021","volume":"29","author":"JW Gu","year":"2014","unstructured":"Gu JW, Yang T, Kuang YQ, Huang HD, Kong B, Shu HF, et al. Comparison of the safety and efficacy of propofol with midazolam for sedation of patients with severe traumatic brain injury: a meta-analysis. J Crit Care. 2014;29(2):287\u201390.","journal-title":"J Crit Care"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01592-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-022-01592-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01592-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T08:40:25Z","timestamp":1646383225000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-022-01592-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1592"],"URL":"https:\/\/doi.org\/10.1186\/s12871-022-01592-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-490861\/v1","asserted-by":"object"}]},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"3 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experiments were approved by the Federal Animal Care Committee (Landesuntersuchungsamt Rheinland-Pfalz, protocol number 23 177-07\/ G 12-1-010) in accordance with the ARRIVE guidelines. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}